본문으로 건너뛰기
← 뒤로

Association of immune-related adverse events with survival in patients receiving immune checkpoint inhibitor plus chemotherapy for lung cancer.

1/5 보강
Scientific reports 📖 저널 OA 98% 2021: 24/24 OA 2022: 32/32 OA 2023: 45/45 OA 2024: 140/140 OA 2025: 938/938 OA 2026: 727/767 OA 2021~2026 2026 OA Cancer Immunotherapy and Biomarkers
Retraction 확인
출처
PubMed DOI OpenAlex 마지막 보강 2026-04-30
OpenAlex 토픽 · Cancer Immunotherapy and Biomarkers Multiple and Secondary Primary Cancers Lung Cancer Research Studies

Takada S, Nasu I, Uozumi R, Kondo M, Nawata S, Iihara H

📖 무료 전문 🔓 OA PDF oa

이 논문을 인용하기

↓ .bib ↓ .ris
APA Shinya Takada, Izumi Nasu, et al. (2026). Association of immune-related adverse events with survival in patients receiving immune checkpoint inhibitor plus chemotherapy for lung cancer.. Scientific reports. https://doi.org/10.1038/s41598-026-46185-7
MLA Shinya Takada, et al.. "Association of immune-related adverse events with survival in patients receiving immune checkpoint inhibitor plus chemotherapy for lung cancer.." Scientific reports, 2026.
PMID 41932994 ↗

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (3)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🔓 OA PDF 열기